Open AccessSuccessful treatment of adult‐onset nesidioblastosis by continuous subcutaneous octreotide infusion in a patient on hemodialysis
Author(s) -
Kato Rina,
Nishimura Akihiro,
Matsumura Kimio,
Kikuno Shota,
Nagasawa Kaoru,
Mori Yasumichi
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3514
Subject(s) - medicine , nesidioblastosis , octreotide , hemodialysis , hypoglycemia , hyperinsulinemic hypoglycemia , subcutaneous injection , surgery , anesthesia , insulin , somatostatin
Octreotide may be useful in noninsulinoma pancreatogenous hypoglycemia syndrome with nesidioblastosis patients who was on hemodialysis. Continuous octreotide subcutaneous infusion can reduce side‐effects and stabilize plasma glucose levels.